Flamingo Therapeutics Announces Appointment of Andrew E. Denker, MD, PhD, as Chief Medical Officer
/PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced the appointment of Andrew E. Denker, MD, PhD., as Chief Medical Officer. Dr. Denker is a...
Source: prnewswire.com